Journal of Long-Term Effects of Medical Implants

ISSN for PRINT: 1050-6934

For Online Access

Best Paper Award Selection - Editorial Board Site

2002, Volume12

Issue 4

106 pages

Issue price - $175.00

Richard F. Edlich
Biomedical Engineering and Emergency Medicine, University of Virginia Health System, Trauma Specialists LLP, Legacy Verify Level I Shock Trauma Center for Pediatrics and Adults, Legacy Emanuel Hospital, Portland, OR, USA

Robin R. Szarmach, CST/CFA
Consorta, Inc., Catholic Resource Partners, Rolling Meadows, Illinois

Jean Livingston, RN, PhD
Consorta, Inc., Catholic Resource Partners, Rolling Meadows, Illinois

George T. Rodeheaver, PhD
Distinguished Research Professor of Plastic Surgery. Plastic Surgery Research Program, University of Virginia Health System, P.O. Box 801351 Charlottesville, VA 22908-1351, USA

John G. Thacker, PhD
Department of Mechanical and Aerospace Engineering, University of Virginia, Charlottesville, Virginia

This report describes an innovative suture and needle clinical evaluation program jointly designed by hospital representatives of Consorta, Inc., a healthcare resource management and group purchasing organization, and United States Surgical/Davis & Geck Sutures (USS/D&G), manufacturer of surgical biomaterials. Nineteen Consorta shareholder hospitals enrolled 699 surgeons to participate in Phase I of this nonexperimental observational study of the clinical performance of surgical needles and sutures. Performance characteristics of the sutures and needles produced by USS/D&G, which were evaluated in 3407 surgical procedures, included packaging and ease of opening, needle strength and sharpness, tissue drag, knot security, tensile strength, and clinically acceptable and unacceptable determinations. In these 30-day studies, the surgeons concluded that the needles and sutures were clinically acceptable in 98.1% of the evaluations. 6 e general, cardiothoracic, and orthopedic surgeons, who performed 73.8% of the product evaluations, reported that the suture and needle products were clinically acceptable in 97.2% of the evaluations. More than half (50.1%) of the evaluations involved the POLISORB* braided synthetic sutures, which received a clinically acceptable rating in 98.4% of the evaluation. The next most frequently used sutures were the SOFSILK*, followed by the monofilament nylon suture. SOFSILK* was found to be clinically acceptable in 98.7% of the evaluations, whereas the monofilament nylon was noted to be clinically acceptable in 96.3% of the evaluations. Surgical needles made by USS/D&G had a 97.9% clinical acceptability rating.

Download article, 20 pages

Article price - $35.00

  Next article >>